Literature DB >> 7726386

Emergency presentations of patients with methylmalonic acidemia, propionic acidemia and branched chain amino acidemia (MSUD).

H Henriquez1, A el Din, P T Ozand, S B Subramanyam, S I al Gain.   

Abstract

The charts of 16 patients with branched chain amino acidemia (MSUD) who had 48 emergency room (ER) visits, of 10 patients with propionic acidemia (PA) who had 57 ER visit, and of 13 patients with methylmalonic acidemia (MMA) who had 154 ER visits, were reviewed retrospectively for the most common clinical presentations, physical and laboratory findings. The most common clinical presentation was acute or chronic vomiting and the most common physical finding was dehydration. When hypoglycemia was found, the mental status of 55% of patients with MSUD and MMA and 20% of patients with PA, was alert. Mixed acid/base disturbance, i.e. alkalosis caused by vomiting mixed with metabolic acidosis caused by the disease, was present in 30% of MSUD, in 33% of PA, and 45% of MMA. There was no relationship between acidosis detected by the blood pH and mental status of the patients. A good correlation between base excess < -5 and serum bicarbonate < 21 mmol/l was found. Blood cultures were positive for bacteria and fungi in 15% of the visits with MSUD, in 23% with PA, and 3% with MMA. Patients with positive blood cultures did not necessarily have a temperature > 39 degrees C nor hypothermia. The results suggest that the mental status of the patients should not detract the ER physician from obtaining blood pH, gases and glucose and in all instances a blood culture should be secured, even if the patient has no fever.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7726386     DOI: 10.1016/0387-7604(94)90101-5

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  9 in total

Review 1.  Acute management of propionic acidemia.

Authors:  Kimberly A Chapman; Andrea Gropman; Erin MacLeod; Kathy Stagni; Marshall L Summar; Keiko Ueda; Nicholas Ah Mew; Jill Franks; Eddie Island; Dietrich Matern; Loren Pena; Brittany Smith; V Reid Sutton; Tiina Urv; Charles Venditti; Anupam Chakrapani
Journal:  Mol Genet Metab       Date:  2011-09-24       Impact factor: 4.797

Review 2.  Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue.

Authors:  Julio C Rojas; Aleksandra K Bruchey; F Gonzalez-Lima
Journal:  Prog Neurobiol       Date:  2011-11-03       Impact factor: 11.685

Review 3.  Reevaluating the hype: four bacterial metabolites under scrutiny.

Authors:  E E Fröhlich; R Mayerhofer; P Holzer
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2015-03-26

4.  Biochemical basis of heterogeneity in acute presentations of propionic acidemia.

Authors:  Seema Pavaman Sindgikar; Suchetha Rao; Rathika D Shenoy; Nutan Kamath
Journal:  Indian J Clin Biochem       Date:  2012-05-05

5.  Defect of cobalamin intracellular metabolism presenting as diabetic ketoacidosis: a rare manifestation.

Authors:  Sheetal Sharda; Suresh Kumar Angurana; Mandeep Walia; Savita Attri
Journal:  JIMD Rep       Date:  2013-04-02

Review 6.  Methylmalonic and propionic acidemias: clinical management update.

Authors:  Jamie L Fraser; Charles P Venditti
Journal:  Curr Opin Pediatr       Date:  2016-12       Impact factor: 2.856

7.  Generation of a hypomorphic model of propionic acidemia amenable to gene therapy testing.

Authors:  Adam J Guenzel; Sean E Hofherr; Matthew Hillestad; Mary Barry; Eric Weaver; Sarah Venezia; Jan P Kraus; Dietrich Matern; Michael A Barry
Journal:  Mol Ther       Date:  2013-05-07       Impact factor: 11.454

8.  Interplay between mitochondria and diet mediates pathogen and stress resistance in Caenorhabditis elegans.

Authors:  Alexey V Revtovich; Ryan Lee; Natalia V Kirienko
Journal:  PLoS Genet       Date:  2019-03-13       Impact factor: 5.917

Review 9.  Brain Branched-Chain Amino Acids in Maple Syrup Urine Disease: Implications for Neurological Disorders.

Authors:  Jing Xu; Youseff Jakher; Rebecca C Ahrens-Nicklas
Journal:  Int J Mol Sci       Date:  2020-10-11       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.